367 related articles for article (PubMed ID: 38203175)
1. Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy.
Nenkov M; Shi Y; Ma Y; Gaßler N; Chen Y
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203175
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5.
Trammell SAJ; Svenningsen JS; Holst JJ; Gillum MP; Kuhre RE
Molecules; 2020 May; 25(10):. PubMed ID: 32443832
[TBL] [Abstract][Full Text] [Related]
3. Policosanol alleviates hepatic lipid accumulation by regulating bile acids metabolism in C57BL6/mice through AMPK-FXR-TGR5 cross-talk.
Zhai Z; Niu KM; Liu H; Lin C; Tu Y; Liu Y; Cai L; Ouyang K; Liu J
J Food Sci; 2021 Dec; 86(12):5466-5478. PubMed ID: 34730235
[TBL] [Abstract][Full Text] [Related]
4. Regulation of bile acid receptor activity
Wan YY; Sheng L
Liver Res; 2018 Dec; 2(4):180-185. PubMed ID: 32280557
[TBL] [Abstract][Full Text] [Related]
5. Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases.
Guan B; Tong J; Hao H; Yang Z; Chen K; Xu H; Wang A
Acta Pharm Sin B; 2022 May; 12(5):2129-2149. PubMed ID: 35646540
[TBL] [Abstract][Full Text] [Related]
6. Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR.
Jadhav K; Xu Y; Xu Y; Li Y; Xu J; Zhu Y; Adorini L; Lee YK; Kasumov T; Yin L; Zhang Y
Mol Metab; 2018 Mar; 9():131-140. PubMed ID: 29361497
[TBL] [Abstract][Full Text] [Related]
7. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
[TBL] [Abstract][Full Text] [Related]
8. The regulation of tissue-specific farnesoid X receptor on genes and diseases involved in bile acid homeostasis.
Xiang D; Yang J; Liu L; Yu H; Gong X; Liu D
Biomed Pharmacother; 2023 Dec; 168():115606. PubMed ID: 37812893
[TBL] [Abstract][Full Text] [Related]
9. A novel role for farnesoid X receptor in the bile acid-mediated intestinal glucose homeostasis.
Zhao L; Xuan Z; Song W; Zhang S; Li Z; Song G; Zhu X; Xie H; Zheng S; Song P
J Cell Mol Med; 2020 Nov; 24(21):12848-12861. PubMed ID: 33029898
[TBL] [Abstract][Full Text] [Related]
10. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
[TBL] [Abstract][Full Text] [Related]
11. Bile acid nuclear receptor FXR and digestive system diseases.
Ding L; Yang L; Wang Z; Huang W
Acta Pharm Sin B; 2015 Mar; 5(2):135-44. PubMed ID: 26579439
[TBL] [Abstract][Full Text] [Related]
12. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.
Watanabe M; Houten SM; Mataki C; Christoffolete MA; Kim BW; Sato H; Messaddeq N; Harney JW; Ezaki O; Kodama T; Schoonjans K; Bianco AC; Auwerx J
Nature; 2006 Jan; 439(7075):484-9. PubMed ID: 16400329
[TBL] [Abstract][Full Text] [Related]
13. Bisphenol A induced hepatic steatosis by disturbing bile acid metabolism and FXR/TGR5 signaling pathways via remodeling the gut microbiota in CD-1 mice.
Hong T; Zou J; He Y; Zhang H; Liu H; Mai H; Yang J; Cao Z; Chen X; Yao J; Feng D
Sci Total Environ; 2023 Sep; 889():164307. PubMed ID: 37211107
[TBL] [Abstract][Full Text] [Related]
14. Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration.
Li G; L Guo G
Acta Pharm Sin B; 2015 Mar; 5(2):93-8. PubMed ID: 26579433
[TBL] [Abstract][Full Text] [Related]
15. Bile acids as regulators of hepatic lipid and glucose metabolism.
Trauner M; Claudel T; Fickert P; Moustafa T; Wagner M
Dig Dis; 2010; 28(1):220-4. PubMed ID: 20460915
[TBL] [Abstract][Full Text] [Related]
16. Polyphenol-induced improvements in glucose metabolism are associated with bile acid signaling to intestinal farnesoid X receptor.
Tveter KM; Villa-Rodriguez JA; Cabales AJ; Zhang L; Bawagan FG; Duran RM; Roopchand DE
BMJ Open Diabetes Res Care; 2020 Aug; 8(1):. PubMed ID: 32771984
[TBL] [Abstract][Full Text] [Related]
17. Bile Acid Receptors and Gastrointestinal Functions.
Ticho AL; Malhotra P; Dudeja PK; Gill RK; Alrefai WA
Liver Res; 2019 Mar; 3(1):31-39. PubMed ID: 32368358
[TBL] [Abstract][Full Text] [Related]
18. Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart.
Hanafi NI; Mohamed AS; Sheikh Abdul Kadir SH; Othman MHD
Biomolecules; 2018 Nov; 8(4):. PubMed ID: 30486474
[TBL] [Abstract][Full Text] [Related]
19. The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer.
Sun L; Cai J; Gonzalez FJ
Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):335-347. PubMed ID: 33568795
[TBL] [Abstract][Full Text] [Related]
20. Farnesoid X Receptor Constructs an Immunosuppressive Microenvironment and Sensitizes FXR
You W; Li L; Sun D; Liu X; Xia Z; Xue S; Chen B; Qin H; Ai J; Jiang H
Cancer Immunol Res; 2019 Jun; 7(6):990-1000. PubMed ID: 30975694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]